1
2
Loonstra, Floor C., Hoitsma, Elske, van Kempen, Zoé L.E., Killestein, Joep, Mostert, Jop P.
Veröffentlicht in: Loonstra , F C , Hoitsma , E , van Kempen , Z L E , Killestein , J & Mostert , J P 2020 , ' COVID-19 in multiple sclerosis : The Dutch experience ' , Multiple Sclerosis Journal , vol. 26 , no. 10 , pp. 1256-1260 . https://doi.org/10.1177/1352458520942198;
2020
Veröffentlicht in: Loonstra , F C , Hoitsma , E , van Kempen , Z L E , Killestein , J & Mostert , J P 2020 , ' COVID-19 in multiple sclerosis : The Dutch experience ' , Multiple Sclerosis Journal , vol. 26 , no. 10 , pp. 1256-1260 . https://doi.org/10.1177/1352458520942198;
2020
3
Boekel, Laura, Steenhuis, Maurice, Hooijberg, Femke, Besten, Yaëlle R, van Kempen, Zoé L E, Kummer, Laura Y, van Dam, Koos P J, Stalman, Eileen W, Vogelzang, Erik H, Cristianawati, Olvi, Keijzer, Sofie, Vidarsson, Gestur, Voskuyl, Alexandre E, Wieske, Luuk, Eftimov, Filip, van Vollenhoven, Ronald, Kuijpers, Taco W, van Ham, S Marieke, Tas, Sander W, Killestein, Joep, Boers, Maarten, Nurmohamed, Michael T, Rispens, Theo, Wolbink, Gertjan
Veröffentlicht in: The Lancet Rheumatology ; volume 3, issue 11, page e778-e788 ; ISSN 2665-9913;
2021
Veröffentlicht in: The Lancet Rheumatology ; volume 3, issue 11, page e778-e788 ; ISSN 2665-9913;
2021
4
Boekel, Laura, Steenhuis, Maurice, Hooijberg, Femke, Besten, Yaëlle R., van Kempen, Zoé L. E., Kummer, Laura Y., van Dam, Koos P. J., Stalman, Eileen W., Vogelzang, Erik H., Cristianawati, Olvi, Keijzer, Sofie, Vidarsson, Gestur, Voskuyl, Alexandre E., Wieske, Luuk, Eftimov, Filip, van Vollenhoven, Ronald, Kuijpers, Taco W., van Ham, S. Marieke, Tas, Sander W., Killestein, Joep, Boers, Maarten, Nurmohamed, Michael T., Rispens, Theo, Wolbink, Gertjan
Veröffentlicht in: Boekel , L , Steenhuis , M , Hooijberg , F , Besten , Y R , van Kempen , Z L E , Kummer , L Y , van Dam , K P J , Stalman , E W , Vogelzang , E H , Cristianawati , O , Keijzer , S , Vidarsson , G , Voskuyl , A E , Wieske , L , Eftimov , F , van Vollenhoven , R , Kuijpers , T W , van Ham , S M , Tas , S W , Killestein , J , Boers , M , Nurmohamed , M T , Rispens , T & Wolbink , G 2021 , ' Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands : a substudy of data from two prospective cohort studies ' , The Lancet Rheumatology , vol. 3 , no. 11 , pp. e778-e788 . https://doi.org/10.1016/S2665-9913(21)00222-8 , https://doi.org/10.1016/S2665-9913(21)00222-8;
2021
Veröffentlicht in: Boekel , L , Steenhuis , M , Hooijberg , F , Besten , Y R , van Kempen , Z L E , Kummer , L Y , van Dam , K P J , Stalman , E W , Vogelzang , E H , Cristianawati , O , Keijzer , S , Vidarsson , G , Voskuyl , A E , Wieske , L , Eftimov , F , van Vollenhoven , R , Kuijpers , T W , van Ham , S M , Tas , S W , Killestein , J , Boers , M , Nurmohamed , M T , Rispens , T & Wolbink , G 2021 , ' Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands : a substudy of data from two prospective cohort studies ' , The Lancet Rheumatology , vol. 3 , no. 11 , pp. e778-e788 . https://doi.org/10.1016/S2665-9913(21)00222-8 , https://doi.org/10.1016/S2665-9913(21)00222-8;
2021